Takeaway
In multiple sclerosis (MS), the strongest pathological correlate of magnetization transfer ratio (MTR) was myelin immunostaining intensity.
Why this matters
Changes in MTR have been used to measure treatment effectiveness in clinical trials and reveal MS progression in vivo, however, the pathological determinant of these changes is unknown.